Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person UniProt:Q16850-1 CYP51A1
| Class:Id | ReferenceIsoform:424684 |
|---|---|
| _chainChangeLog | chain:1-503 added on Fri February 6 2015;chain:1-503 for 424684 removed on Fri February 25 2022;chain:1-509 for 424684 added on Fri February 25 2022 |
| _displayName | UniProt:Q16850-1 CYP51A1 |
| _timestamp | 2025-08-15 21:29:15 |
| chain | chain:1-509 |
| checksum | F9145DDB65F94091 |
| comment | FUNCTION Sterol 14alpha-demethylase that plays a critical role in the cholesterol biosynthesis pathway, being cholesterol the major sterol component in mammalian membranes as well as a precursor for bile acid and steroid hormone synthesis (PubMed:20149798, PubMed:8619637, PubMed:9559662). Cytochrome P450 monooxygenase that catalyzes the three-step oxidative removal of the 14alpha-methyl group (C-32) of sterols such as lanosterol (lanosta-8,24-dien-3beta-ol) and 24,25-dihydrolanosterol (DHL) in the form of formate, and converts the sterols to 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol and 4,4-dimethyl-8,14-cholestadien-3beta-ol, respectively, which are intermediates of cholesterol biosynthesis (PubMed:20149798, PubMed:8619637, PubMed:9559662). Can also demethylate substrates not intrinsic to mammals, such as eburicol (24-methylene-24,25-dihydrolanosterol), but at a lower rate than DHL (PubMed:9559662).CATALYTIC ACTIVITY a 14alpha-methyl steroid + 3 reduced [NADPH--hemoprotein reductase] + 3 O2 = a Delta(14) steroid + formate + 3 oxidized [NADPH--hemoprotein reductase] + 4 H2O + 4 H(+)CATALYTIC ACTIVITY lanosterol + 3 reduced [NADPH--hemoprotein reductase] + 3 O2 = 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + 3 oxidized [NADPH--hemoprotein reductase] + 4 H2O + 4 H(+)CATALYTIC ACTIVITY 24,25-dihydrolanosterol + 3 reduced [NADPH--hemoprotein reductase] + 3 O2 = 4,4-dimethyl-8,14-cholestadien-3beta-ol + formate + 3 oxidized [NADPH--hemoprotein reductase] + 4 H2O + 4 H(+)CATALYTIC ACTIVITY a 14alpha-methyl steroid + reduced [NADPH--hemoprotein reductase] + O2 = a 14alpha-hydroxymethyl steroid + oxidized [NADPH--hemoprotein reductase] + H2O + H(+)CATALYTIC ACTIVITY a 14alpha-hydroxymethyl steroid + reduced [NADPH--hemoprotein reductase] + O2 = a 14alpha-formyl steroid + oxidized [NADPH--hemoprotein reductase] + 2 H2O + H(+)CATALYTIC ACTIVITY a 14alpha-formyl steroid + reduced [NADPH--hemoprotein reductase] + O2 = a Delta(14) steroid + formate + oxidized [NADPH--hemoprotein reductase] + H2O + 2 H(+)CATALYTIC ACTIVITY lanosterol + reduced [NADPH--hemoprotein reductase] + O2 = 32-hydroxylanosterol + oxidized [NADPH--hemoprotein reductase] + H2O + H(+)CATALYTIC ACTIVITY 32-hydroxylanosterol + reduced [NADPH--hemoprotein reductase] + O2 = 32-oxolanosterol + oxidized [NADPH--hemoprotein reductase] + 2 H2O + H(+)CATALYTIC ACTIVITY 32-oxolanosterol + reduced [NADPH--hemoprotein reductase] + O2 = 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol + formate + oxidized [NADPH--hemoprotein reductase] + H2O + 2 H(+)CATALYTIC ACTIVITY 24,25-dihydrolanosterol + reduced [NADPH--hemoprotein reductase] + O2 = 32-hydroxy-24,25-dihydrolanosterol + oxidized [NADPH--hemoprotein reductase] + H2O + H(+)CATALYTIC ACTIVITY 32-hydroxy-24,25-dihydrolanosterol + reduced [NADPH--hemoprotein reductase] + O2 = 32-oxo-24,25-dihydrolanosterol + oxidized [NADPH--hemoprotein reductase] + 2 H2O + H(+)CATALYTIC ACTIVITY 32-oxo-24,25-dihydrolanosterol + reduced [NADPH--hemoprotein reductase] + O2 = 4,4-dimethyl-8,14-cholestadien-3beta-ol + formate + oxidized [NADPH--hemoprotein reductase] + H2O + 2 H(+)COFACTOR Inhibited by azalanstat. Inhibited by azole antifungal agents ketoconazole, itraconazole and fluconazole.BIOPHYSICOCHEMICAL PROPERTIES Steroid biosynthesis; zymosterol biosynthesis; zymosterol from lanosterol: step 1/6.SUBCELLULAR LOCATION Ubiquitously expressed with highest levels in testis, ovary, adrenal, prostate, liver, kidney and lung.PTM Ubiquitinated by MARCHF6, leading to proteasomal degradation.SIMILARITY Belongs to the cytochrome P450 family.CAUTION It is uncertain whether Met-1 or Met-7 is the initiator.SEQUENCE CAUTION Truncated N-terminus. |
| created | [InstanceEdit:423310] Kanapin, AA |
| description | recommendedName: fullName evidence="8"Lanosterol 14-alpha demethylase shortName: LDM ecNumber evidence="3 5 6"1.14.14.154 alternativeName: CYPLI alternativeName: Cytochrome P450 51A1 shortName: CYP51A1 alternativeName: Cytochrome P450-14DM shortName: Cytochrome P45014DM alternativeName: Cytochrome P450LI alternativeName: Sterol 14-alpha demethylase |
| geneName | CYP51A1 CYP51 |
| identifier | Q16850 |
| isoformParent | |
| isSequenceChanged | FALSE |
| keyword | 3D-structure Alternative splicing Cholesterol biosynthesis Cholesterol metabolism Endoplasmic reticulum Heme Iron Lipid biosynthesis Lipid metabolism Membrane Metal-binding Microsome Monooxygenase Oxidoreductase Proteomics identification Reference proteome Steroid biosynthesis Steroid metabolism Sterol biosynthesis Sterol metabolism Transmembrane Transmembrane helix Ubl conjugation |
| modified | [InstanceEdit:9836292] Weiser, Joel, 2023-05-25 [InstanceEdit:9852000] Weiser, Joel, 2023-11-03 [InstanceEdit:9862192] Weiser, Joel, 2024-02-26 [InstanceEdit:9917590] Weiser, Joel, 2024-08-09 [InstanceEdit:9926675] Weiser, Joel, 2024-11-03 [InstanceEdit:9939033] Weiser, Joel, 2025-02-21 [InstanceEdit:9963647] Weiser, Joel, 2025-08-15 |
| name | CYP51A1 |
| referenceDatabase | [ReferenceDatabase:2] UniProt |
| referenceGene | [ReferenceDNASequence:5660082] ENSEMBL:ENSG00000001630 CYP51A1 [Homo sapiens] |
| secondaryIdentifier | CP51A_HUMAN A0A0C4DFL7 A4D1F8 B2RAI4 B4DJ55 O00770 O00772 Q16784 Q8N1A8 Q99868 |
| sequenceLength | 509 |
| species | [Species:48887] Homo sapiens |
| variantIdentifier | Q16850-1 |
| [Change default viewing format] | |
No pathways have been reviewed or authored by UniProt:Q16850-1 CYP51A1 (424684)
